NCT02246647View on ClinicalTrials.gov

Biomarkers for Intestinal Permeability in Patients With Constipation

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 8, 2016

Study Completion Date

December 8, 2016

Conditions
Intestinal DiseasesIrritable Bowel SyndromeConstipation
Interventions
DIAGNOSTIC_TEST

Permeability measurement

Saccharide excretion was compared between IBS-C and healthy volunteers

PROCEDURE

Esophagogastroduodenoscopy

Duodenal biopsies were collected from IBS-C and healthy volunteers

PROCEDURE

Flexible sigmoidoscopy

Colonic biopsies were collected from IBS-C and healthy volunteers

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Takeda Pharmaceuticals International, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER

NCT02246647 - Biomarkers for Intestinal Permeability in Patients With Constipation | Biotech Hunter | Biotech Hunter